Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Springer

Showing results (251-260 of 280) with videos related to

Pageof 28
Sort By:
Cancer Research|September 3, 2010
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAFSteven Whittaker, Delphine Ménard, Ruth Kirk, et al.
Cell|March 24, 2004
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAFPaul T C Wan, Mathew J Garnett, S Mark Roe, et al.
Annals of Family Medicine|April 11, 2018
Use of Quality Improvement Strategies Among Small to Medium-Size US Primary Care PracticesBijal A Balasubramanian, Miguel Marino, Deborah J Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrugAstrid Mayer, Roslyn J Francis, Surinder K Sharma, et al.
G3 (Bethesda, Md.)|June 13, 2012
Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrataYing-Lien Chen, Jay H Konieczka, Deborah J Springer, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Molecular Cancer Therapeutics|October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell CarcinomaVictoria L Bridgeman, Elaine Wan, Shane Foo, et al.
Journal of Medicinal Chemistry|February 13, 2010
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ringArnaud Nourry, Alfonso Zambon, Lawrence Davies, et al.
Plos One|June 4, 2010
Morphological and molecular characterizations of psychrophilic fungus Geomyces destructans from New York bats with White Nose Syndrome (WNS)Vishnu Chaturvedi, Deborah J Springer, Melissa J Behr, et al.
Cancer Research|October 13, 2019
Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance ElastographyJin Li, Konstantinos Zormpas-Petridis, Jessica K R Boult, et al.
Pageof 28

Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Cancer Research|September 3, 2010
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAFSteven Whittaker, Delphine Ménard, Ruth Kirk, et al.
Cell|March 24, 2004
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAFPaul T C Wan, Mathew J Garnett, S Mark Roe, et al.
Annals of Family Medicine|April 11, 2018
Use of Quality Improvement Strategies Among Small to Medium-Size US Primary Care PracticesBijal A Balasubramanian, Miguel Marino, Deborah J Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrugAstrid Mayer, Roslyn J Francis, Surinder K Sharma, et al.
G3 (Bethesda, Md.)|June 13, 2012
Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrataYing-Lien Chen, Jay H Konieczka, Deborah J Springer, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Molecular Cancer Therapeutics|October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell CarcinomaVictoria L Bridgeman, Elaine Wan, Shane Foo, et al.
Journal of Medicinal Chemistry|February 13, 2010
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ringArnaud Nourry, Alfonso Zambon, Lawrence Davies, et al.
Plos One|June 4, 2010
Morphological and molecular characterizations of psychrophilic fungus Geomyces destructans from New York bats with White Nose Syndrome (WNS)Vishnu Chaturvedi, Deborah J Springer, Melissa J Behr, et al.
Cancer Research|October 13, 2019
Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance ElastographyJin Li, Konstantinos Zormpas-Petridis, Jessica K R Boult, et al.
Pageof 28